TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
2017
Blenis, John
Michael N. Hall is this year’s recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell’s growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
Elsevier Inc.
其它主题
Cell growth; Biomedical research; Neurodegenerative diseases; Rapamycin
语言
英语
类型
Journal Article; Text
2024-02-28
MODS